Emerging SARS-CoV-2 Mutational Variants of Concern Should Not Vary in Susceptibility to Microbicidal Actives

被引:0
|
作者
Ijaz, M. Khalid [1 ]
Nims, Raymond W. [2 ]
McKinney, Julie [1 ]
机构
[1] Reckitt Benckiser LLC, Global Res & Dev Lysol & Dettol, One Phillips Dr, Montvale, NJ 07645 USA
[2] RMC Pharmaceut Solut, Longmont, CO 80501 USA
来源
LIFE-BASEL | 2022年 / 12卷 / 07期
关键词
coronavirus; COVID-19; decontamination of surfaces and hands; Beta variant; Delta variant; formulated microbicidal active; hierarchy of microbicidal susceptibility to pathogens; SARS-CoV-2; viral inactivation; virucidal efficacy; TRANSMISSION; OMICRON; COVID-19;
D O I
10.3390/life12070987
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is evolving, with emergence of mutational variants due to the error-prone replication process of RNA viruses, in general. More recently, the Delta and Omicron variants (including sub-variants BA.1-5) predominate globally, and a Delta-Omicron recombinant termed Deltacron has emerged. The emergence of variants of concern (VOC) demonstrating immune evasion and potentially greater transmissibility and virulence naturally raises concern in both the infection control communities and the public at large, as to the continued suitability of interventions intended to mitigate the risk of viral dissemination and acquisition of the associated disease COVID-19. We evaluated the virucidal efficacy of targeted surface hygiene products (an ethanol/quaternary ammonium compound (QAC)-containing disinfectant spray, a QAC disinfectant wipe, a lactic acid disinfectant wipe, and a citric acid disinfectant wipe) through both theoretical arguments and empirical testing using international standard methodologies (ASTM E1053-20 hard surface test and EN14476:2013+A2:2019 suspension test) in the presence of soil loads simulating patients' bodily secretions/excretions containing shed virus. The results demonstrate, as expected, complete infectious viral inactivation (>= 3.0 to >= 4.7 log(10) reduction in infectious virus titer after as little as 15 s contact time at room temperature) by these surface hygiene agents of the original SARS-CoV-2 isolate and its Beta and Delta VOC. Through appropriate practices of targeted surface hygiene, it is expected that irrespective of the SARS-CoV-2 VOC encountered as the current pandemic unfolds (and, for that matter, any emerging and/or re-emerging enveloped virus), the chain of infection from virus-contaminated fomites to the hand and mucous membranes of a susceptible person may be disrupted.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Immune Profile of SARS-CoV-2 Variants of Concern
    La Porta, Caterina A. M.
    Zapperi, Stefano
    FRONTIERS IN DIGITAL HEALTH, 2021, 3
  • [32] A comparison of transmissibility of SARS-CoV-2 variants of concern
    S. S. Manathunga
    I. A. Abeyagunawardena
    S. D. Dharmaratne
    Virology Journal, 20
  • [33] A comparison of transmissibility of SARS-CoV-2 variants of concern
    Manathunga, S. S.
    Abeyagunawardena, I. A.
    Dharmaratne, S. D.
    VIROLOGY JOURNAL, 2023, 20 (01)
  • [34] Application of nanomaterials against SARS-CoV-2: An emphasis on their usefulness against emerging variants of concern
    Iqbal, Reema
    Khan, Sadia
    Ali, Haroon Muhammad
    Khan, Maham
    Wahab, Shahid
    Khan, Tariq
    FRONTIERS IN NANOTECHNOLOGY, 2022, 4
  • [35] Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern
    Carter-Timofte, Madalina Elena
    Arulanandam, Rozanne
    Kurmasheva, Naziia
    Fu, Kathy
    Laroche, Genevieve
    Taha, Zaid
    van Der Horst, Demi
    Cassin, Lena
    van der Sluis, Renee M.
    Palermo, Enrico
    Di Carlo, Daniele
    Jacobs, David
    Maznyi, Glib
    Azad, Taha
    Singaravelu, Ragunath
    Ren, Fanghui
    Hansen, Anne Louise
    Idorn, Manja
    Holm, Christian K.
    Jakobsen, Martin R.
    van Grevenynghe, Julien
    Hiscott, John
    Paludan, Soren R.
    Bell, John C.
    Seguin, Jean
    Sabourin, Luc A.
    Cote, Marceline
    Diallo, Jean-Simon
    Alain, Tommy
    Olagnier, David
    ACS INFECTIOUS DISEASES, 2021, 7 (11): : 3034 - 3051
  • [36] Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model
    Abdelnabi, Rana
    Foo, Caroline S.
    De Jonghe, Steven
    Maes, Piet
    Weynand, Birgit
    Neyts, Johan
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (05): : 749 - 753
  • [37] Developing pan-β-coronavirus vaccines against emerging SARS-CoV-2 variants of concern
    Su, Shan
    Li, Weihua
    Jiang, Shibo
    TRENDS IN IMMUNOLOGY, 2022, 43 (03) : 170 - 172
  • [38] Evolutionary trajectory of SARS-CoV-2 and emerging variants
    Jalen Singh
    Pranav Pandit
    Andrew G. McArthur
    Arinjay Banerjee
    Karen Mossman
    Virology Journal, 18
  • [39] Emerging SARS-CoV-2 variants: shooting the messenger
    不详
    LANCET INFECTIOUS DISEASES, 2022, 22 (01): : 1 - 1
  • [40] Interferon resistance of emerging SARS-CoV-2 variants
    Guo, Kejun
    Barrett, Bradley S.
    Morrison, James H.
    Mickens, Kaylee L.
    Vladar, Eszter K.
    Hasenkrug, Kim J.
    Poeschla, Eric M.
    Santiago, Mario L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (32)